Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, pharmacokinetics, and pharmacodynamics of K-757 and K-833 in overweight/obese patients with Type 2 Diabetes has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• K-757
• K-833

Snippet

Sponsor: Kallyope Inc. | Conditions: Obesity, Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Status: COMPLETED